# VAccination to Improve Clinical outComes in Heart Failure Trial: a Feasibility Study (VACC-HeFT)

> **NCT02268500** · PHASE4 · COMPLETED · sponsor: **University of Wisconsin, Madison** · enrollment: 48 (actual)

## Conditions studied

- Chronic Heart Failure

## Interventions

- **BIOLOGICAL:** Influenza vaccine

## Key facts

- **NCT ID:** NCT02268500
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2016-01
- **Final completion:** 2016-05
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2021-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02268500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02268500, "VAccination to Improve Clinical outComes in Heart Failure Trial: a Feasibility Study (VACC-HeFT)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02268500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*